These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6896689)

  • 1. Evidence for enzymatic reduction of 1-nitropyrene by rat liver fractions.
    Nachtman JP; Wei ET
    Experientia; 1982 Jul; 38(7):837-8. PubMed ID: 6896689
    [No Abstract]   [Full Text] [Related]  

  • 2. Participation of cytochrome P-450 in reductive metabolism of 1-nitropyrene by rat liver microsomes.
    Saito K; Kamataki T; Kato R
    Cancer Res; 1984 Aug; 44(8):3169-73. PubMed ID: 6430544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Nitropyrene-metabolizing activities of fish liver preparations.
    Kitamura S; Tatsumi K
    Bull Environ Contam Toxicol; 1997 Mar; 58(3):448-55. PubMed ID: 9008056
    [No Abstract]   [Full Text] [Related]  

  • 4. Aerobic and anaerobic reduction of nitrated pyrenes in vitro.
    Djurić Z; Potter DW; Heflich RH; Beland FA
    Chem Biol Interact; 1986 Oct; 59(3):309-24. PubMed ID: 3021349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA binding by 1-nitropyrene and 1,6-dinitropyrene in vitro and in vivo: effects of nitroreductase induction.
    Djurić Z; Fifer EK; Yamazoe Y; Beland FA
    Carcinogenesis; 1988 Mar; 9(3):357-64. PubMed ID: 3345577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of C8-modified deoxyguanosine and C8-modified deoxyadenosine as major DNA adducts from 2-nitropyrene metabolism mediated by rat and mouse liver microsomes and cytosols.
    Fu PP; Miller DW; Von Tungeln LS; Bryant MS; Lay JO; Huang K; Jones L; Evans FE
    Carcinogenesis; 1991 Apr; 12(4):609-16. PubMed ID: 2013125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA binding by 1-nitropyrene and dinitropyrenes in vitro and in vivo: effects of nitroreductase induction.
    Beland FA
    Res Rep Health Eff Inst; 1989 Nov; (31):1-16. PubMed ID: 2604921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of nitro reduction by rat liver.
    Kato R; Oshima T; Takanaka A
    Mol Pharmacol; 1969 Sep; 5(5):487-98. PubMed ID: 4390447
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of ring oxidation in the metabolic activation of 1-nitropyrene.
    Beland FA
    Res Rep Health Eff Inst; 1991 Dec; (46):1-22; discussion 23-33. PubMed ID: 1777157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of nitro reduction of the carcinogenic agent, 4-nitroINOLONE N-oxide.
    Kato R; Takahashi A; Oshima T
    Biochem Pharmacol; 1970 Jan; 19(1):45-55. PubMed ID: 4101191
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of rat liver cytosolic enzymes and cofactors on mutagenicity of 1-amino-8-nitropyrene.
    Martire G; Villani GR; Della Morte R; Belisario MA; Pecce R; Staiano N
    Carcinogenesis; 1991 Feb; 12(2):361-4. PubMed ID: 1995197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Nitropyrene reduction by Salmonella typhimurium, V79 Chinese hamster and primary rat liver cells.
    Salmeen I; Zacmanidis P; Ball J
    Mutat Res; 1983 Oct; 122(1):23-8. PubMed ID: 6353221
    [No Abstract]   [Full Text] [Related]  

  • 13. Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity.
    De Flora S; Morelli A; Basso C; Romano M; Serra D; De Flora A
    Cancer Res; 1985 Jul; 45(7):3188-96. PubMed ID: 4005852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and mutagenicity of 1-nitropyrene 4,5-oxide and 1-nitropyrene 9,10-oxide, microsomal metabolites of 1-nitropyrene.
    Fifer EK; Howard PC; Heflich RH; Beland FA
    Mutagenesis; 1986 Nov; 1(6):433-8. PubMed ID: 3331683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of cytosolic components activating rat hepatic 5' [corrected]-deiodination in the presence of NADPH.
    Sawada K; Hummel BC; Walfish PG
    Biochem J; 1986 Mar; 234(2):391-8. PubMed ID: 3718474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the in vitro and in vivo hepatic metabolism of the carcinogen 1-nitropyrene.
    Howard PC; Flammang TJ; Beland FA
    Carcinogenesis; 1985 Feb; 6(2):243-9. PubMed ID: 3838267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfoxide reduction: in vitro reduction of oxyprothepine-8-sulfoxide by rat hepatic cytosolic and microsomal enzymes.
    Helia O; Pauliková I
    Pharmazie; 1993 Oct; 48(10):784-5. PubMed ID: 7903462
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumorigenicity and metabolism of 1-nitropyrene in A/J mice.
    El-Bayoumy K; Hecht SS; Sackl T; Stoner GD
    Carcinogenesis; 1984 Nov; 5(11):1449-52. PubMed ID: 6488469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species differences in metabolic activation and inactivation of 1-nitropyrene in the liver.
    Kataoka K; Kinouchi T; Ohnishi Y
    Cancer Res; 1991 Aug; 51(15):3919-24. PubMed ID: 1855208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicity of oxidized microsomal metabolites of 1-nitropyrene in Chinese hamster ovary cells.
    Heflich RH; Thornton-Manning JR; Kinouchi T; Beland FA
    Mutagenesis; 1990 Mar; 5(2):151-7. PubMed ID: 2188067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.